117 related articles for article (PubMed ID: 32701800)
1. 68Ga-Prostate-Specific Membrane Antigen PET-Positive Paget Bone Disease With Metastatic Prostatic Carcinoma.
Engur CO; Turoglu HT; Ozguven S; Tanidir Y; Erdil TY
Clin Nucl Med; 2020 Sep; 45(9):e425-e426. PubMed ID: 32701800
[TBL] [Abstract][Full Text] [Related]
2. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
3. 68Ga-PSMA PET/CT False-Positive Tracer Uptake in Paget Disease.
Sasikumar A; Joy A; Nanabala R; Pillai MR; T A H
Clin Nucl Med; 2016 Oct; 41(10):e454-5. PubMed ID: 27556797
[TBL] [Abstract][Full Text] [Related]
4. Aspecific Uptake of 68GA-PSMA in Paget Disease of the Bone.
Bourgeois S; Gykiere P; Goethals L; Everaert H; De Geeter FW
Clin Nucl Med; 2016 Nov; 41(11):877-878. PubMed ID: 27556795
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bone scintigraphy and Ga-68 prostate-specific membrane antigen positron emission tomography/computed tomography in the detection of bone metastases of prostate carcinoma.
Soydal C; Nak D; Araz M; Akkus P; Urun Y; Ozkan E; Kucuk NO; Kir MK
Nucl Med Commun; 2019 Dec; 40(12):1243-1249. PubMed ID: 31688499
[TBL] [Abstract][Full Text] [Related]
6. Paget Disease: A Potential Pitfall in PSMA PET for Prostate Cancer.
Blazak JK; Thomas P
Clin Nucl Med; 2016 Sep; 41(9):699-700. PubMed ID: 27405026
[TBL] [Abstract][Full Text] [Related]
7. Multitracer Molecular Imaging of Paget Disease Targeting Bone Remodeling, Fatty Acid Metabolism, and PSMA Expression on PET/CT.
Derlin T; Weiberg D; Sohns JM
Clin Nucl Med; 2016 Dec; 41(12):991-992. PubMed ID: 27749427
[TBL] [Abstract][Full Text] [Related]
8. Comparison of hybrid
Janssen JC; Meißner S; Woythal N; Prasad V; Brenner W; Diederichs G; Hamm B; Makowski MR
Eur Radiol; 2018 Feb; 28(2):610-619. PubMed ID: 28779400
[TBL] [Abstract][Full Text] [Related]
9. Is there a utility of adding skeletal imaging to 68-Ga-prostate-specific membrane antigen-PET/computed tomography in initial staging of patients with high-risk prostate cancer?
Raju S; Sharma A; Patel C; Sahoo R; Das CJ; Kumar S; Sharma A; Kumar R
Nucl Med Commun; 2020 Nov; 41(11):1183-1188. PubMed ID: 32796451
[TBL] [Abstract][Full Text] [Related]
10. 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients.
Schmidkonz C; Cordes M; Goetz TI; Prante O; Kuwert T; Ritt P; Uder M; Wullich B; Goebell P; Bäuerle T
Ann Nucl Med; 2019 Oct; 33(10):766-775. PubMed ID: 31338731
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar Metastases From Prostate Cancer on 68Ga-PSMA PET/CT.
Chan M; Hsiao E; Turner J
Clin Nucl Med; 2017 Mar; 42(3):193-194. PubMed ID: 28033225
[TBL] [Abstract][Full Text] [Related]
12. Osteoporosis Circumscripta on 68Ga-DOTATATE PET CT.
Gandy N; Ordidge KL; Arshad M; Win Z
Clin Nucl Med; 2019 Jun; 44(6):e404-e405. PubMed ID: 30985430
[TBL] [Abstract][Full Text] [Related]
13.
Lengana T; Lawal IO; Boshomane TG; Popoola GO; Mokoala KMG; Moshokoa E; Maes A; Mokgoro NP; Van de Wiele C; Vorster M; Sathekge MM
Clin Genitourin Cancer; 2018 Oct; 16(5):392-401. PubMed ID: 30120038
[TBL] [Abstract][Full Text] [Related]
14. Diffuse Pulmonary Metastases From Prostate Cancer on 68Ga PSMA PET/CT.
Seniaray N; Verma R; Belho E; Malik D; Mahajan H
Clin Nucl Med; 2019 Nov; 44(11):898-900. PubMed ID: 31361647
[TBL] [Abstract][Full Text] [Related]
15.
Basha MAA; Hamed MAG; Hussein O; El-Diasty T; Abdelkhalek YI; Hussein YO; Alasamer AF; Mohamed HAE; Deen DSE; Tantawy EF; Metwally MI; Zaitoun MMA; Aly SA; Altohamy JI; Mohamed AEM; Afifi AHM; Harb O
Abdom Radiol (NY); 2019 Jul; 44(7):2545-2556. PubMed ID: 30963182
[TBL] [Abstract][Full Text] [Related]
16. Paget disease of the humerus mimicking metastatic disease in a patient with metastatic malignant mesothelioma on whole body F-18 FDG PET/CT.
Mahmood S; Martinez de Llano SR
Clin Nucl Med; 2008 Jul; 33(7):510-2. PubMed ID: 18580246
[TBL] [Abstract][Full Text] [Related]
17. Inguinal Canal Deposit-An Uncommon Site of Metastases in Carcinoma Prostate Detected on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Arora S; Kumar S; Das CJ; Jain D; Kumar R
Clin Nucl Med; 2020 Oct; 45(10):e443-e444. PubMed ID: 32796246
[TBL] [Abstract][Full Text] [Related]
18. Factors Predicting Metastatic Disease in
Chiu LW; Lawhn-Heath C; Behr SC; Juarez R; Perez PM; Lobach I; Bucknor MD; Hope TA; Flavell RR
J Nucl Med; 2020 Dec; 61(12):1779-1785. PubMed ID: 32303599
[TBL] [Abstract][Full Text] [Related]
19. Solitary 68Ga-PSMA-Avid Proximal Tibial Prostatic Adenocarcinoma Metastasis Mimicking Enthesopathy.
Hilliar L; Yip JWL; Le K; Loh H; Mansberg R
Clin Nucl Med; 2021 Jan; 46(1):81-83. PubMed ID: 33156056
[TBL] [Abstract][Full Text] [Related]
20. Bone Flare to Androgen Deprivation Therapy in Metastatic, Hormone-Sensitive Prostate Cancer on 68Ga-Prostate-Specific Membrane Antigen PET/CT.
Zacho HD; Petersen LJ
Clin Nucl Med; 2018 Nov; 43(11):e404-e406. PubMed ID: 30222680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
